Epithelial Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Epithelial Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study Comparing BL-M07D1 With Physician's Choice of Chemotherapy in Patients With HER2-Expressing Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer [Phase 3]
Phase 3 clinical trial comparing BL-M07D1 to physician's choice chemotherapy in HER2-expressing platinum-resistant recurrent epithelial ovar…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer(PANKU-GYN01) [Phase 3]
Phase 3 trial evaluating BL-B01D1 vs investigator's choice chemotherapy in platinum-resistant recurrent epithelial ovarian cancer and relate…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study of Isoquercetin in People With Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating isoquercetin in patients with ovarian cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer [EARLY_Phase 1]
A Phase 1 pilot trial (EARLY_PHASE1) assessing weekly paclitaxel, bevacizumab, and zoledronic acid in women with recurrent platinum-resistan…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer. [Phase 2]
Phase 2 clinical trial evaluating intravenous carboplatin in combination with mirvetuximab soravtansine for newly diagnosed FRα-expressing a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells [Phase 1]
Phase 1 clinical trial evaluating autologous CAR-T cells targeting B7-H3 (iC9-CAR.B7-H3 T Cells) for ovarian cancer, currently recruiting at…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2) [Phase 1, Phase 2]
An update on the OVATION 2 study evaluating IMNN-001 (GEN-1) with neoadjuvant chemotherapy for epithelial ovarian cancer, fallopian tube can…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer [Phase 3]
A Phase 3 clinical trial evaluating IMNN-001 in combination with standard neoadjuvant and adjuvant chemotherapy for newly diagnosed advanced…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT [Phase 1]
Phase I pilot study to characterize biodistribution, metabolism, and excretion of the novel PET radiotracer [18F]Fluorthanatrace (FTT) using…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Single-arm, Prospective Clinical Trial of Efficacy and Safety of Daphnetin Capsules Combined With TC Regimen for Targeted Maintenance Therapy After Initial Treatment of Stage III-IV Epithelial Ovarian Cancer (RO/R1) [NA]
A single-arm, prospective clinical trial evaluating the efficacy and safety of Daphnetin capsules combined with the TC chemotherapy regimen …
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT [Phase 1, Phase 2]
This record summarizes ongoing Phase 1 and Phase 2 clinical trials evaluating prehabilitation strategies for ovarian cancer (including epith…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Single-center, Dose-escalation Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Tumor Neoantigen-pulsed Autologous Dendritic Cell Injection (YS247) in Study Participants With HRD-negative Epithelial Ovarian Cancer [NA]
A single-center dose-escalation trial is evaluating the safety, tolerability, and preliminary efficacy of YS247, a tumor neoantigen-pulsed a…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: The PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During Interval Cytoreductive Surgery and HIPEC in Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a PARP inhibitor in combination with cisplatin and hyperthermia during interval cytoreductive surgery an…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors [Phase 2]
The document provides an update on a Phase 2 clinical trial sponsored by Hoffmann-La Roche evaluating biomarker-driven therapies for persist…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Evaluation of Polygenic Risk Score for Epithelial OVarian cancEr Risk Prediction: the PROVE Study
This document reports an ongoing clinical trial (PROVE) evaluating a polygenic risk score to predict epithelial ovarian cancer risk.
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302) [Phase 2]
A Phase 2 clinical trial evaluating tuvusertib in combination with niraparib or lartesertib in participants with epithelial ovarian cancer; …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Determining Prognostic Immune Markers in Patients With Ovarian Cancer
A clinical trial at Leiden University Medical Center is recruiting to identify prognostic immune markers in epithelial ovarian cancer.
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer [NA]
This clinical trial update notes ongoing recruitment for a study evaluating sentinel lymph node detection using Technetium-99m albumin nanoc…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer [NA]
A clinical trial is investigating fasting during neoadjuvant chemotherapy for epithelial ovarian cancer. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer [Phase 3]
Phase 3 trial recruitment is ongoing for AZD5335 versus Mirvetuximab Soravtansine in FRα-high epithelial ovarian cancer and AZD5335 versus c…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. [Phase 2]
A Phase 2 clinical study of TORL-1-23 is evaluating its activity in platinum-resistant ovarian cancer. The trial is currently recruiting acr…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer [NA]
Clinical trial investigating whether hepato-celiac lymphadenectomy affects survival in primary or relapsed epithelial ovarian cancer and rel…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a neoantigen-based dendritic cell vaccine (NEOadjuvant) for ovarian cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: The Immune Landscape of Epithelial Ovarian Cancer
This clinical trial update describes an ongoing study investigating the immune landscape of epithelial ovarian cancer, which is currently re…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating secondary cytoreductive surgery after chemotherapy for recurrent epithelial ovarian cancer is currently …